Today: 10 June 2026
Browse Category

NASDAQ:P3H 15 May 2026

P3 Health Partners turns profit in Q1, lifts 2026 forecast

P3 Health Partners turns profit in Q1, lifts 2026 forecast

P3 Health Partners shares surged over 200% to $13.00 Friday after the company posted its first quarterly profit and raised its 2026 adjusted EBITDA outlook. Net income reached $3 million versus a $44.2 million loss a year earlier, with revenue up 4% to $386 million despite a 10% drop in at-risk membership. The company cited $17 million in one-time benefits, leaving underlying adjusted EBITDA at $8 million.
15 May 2026
··

Stock Market Today

  • Apple Selects Nvidia GPUs for AI Tasks via Google Cloud, Shares Unmoved
    June 10, 2026, 5:10 AM EDT. Apple announced it will use Nvidia GPUs on Google Cloud for demanding AI tasks, marking a shift from its in-house hardware approach. Despite this high-profile nod, Nvidia's shares closed flat at $208.19 amid broader tech sell-offs, including a 1% Nasdaq decline and a 1.9% drop in semiconductor stocks. Apple's move involves running its Private Cloud Compute system, specifically the AFM 3 Cloud Pro model, on Nvidia chips hosted on Google Cloud, highlighting a new collaboration with Google. The deal's revenue impact is unclear as Apple sources Nvidia technology indirectly through Google, positioning Google both as a cloud provider and AI chip competitor with its own tensor processing units (TPUs). Industry watchers note changes in supply chains and a push toward U.S.-based manufacturing amid geopolitical risks.

Latest articles

LVMH Drops Following Quick Rally, RBC Still Sees Recovery for Luxury

LVMH Drops Following Quick Rally, RBC Still Sees Recovery for Luxury

10 June 2026
LVMH shares slipped 0.49% to €489.90 in Paris after a four-day rebound, as investors weighed RBC’s reiterated Buy rating with a €600 target against ongoing 2026 losses and a 24% year-to-date drop; all eyes now turn to July’s first-half results for signs of recovery in Fashion & Leather Goods and any relief from Middle East weakness.
Roche Shares Edge Up After $2.3 Billion Nurix Cancer Pact

Roche Shares Edge Up After $2.3 Billion Nurix Cancer Pact

10 June 2026
Roche’s participation certificates climbed 1.07% to CHF 322.20 after announcing a $2.3 billion deal with Nurix Therapeutics for late-stage blood-cancer drug bexobrutideg, planned to enter Phase 3 trials this summer in CLL, as investors weigh the asset’s potential to offset losses from expiring patents and drive mid-single-digit sales growth in 2026.
YY Group Shares Jump Premarket on Humanoid Robot Move

YY Group Shares Jump Premarket on Humanoid Robot Move

10 June 2026
YYGH jumped to $0.19 in early pre-market after announcing deployment of Unitree G1 humanoid robots for facility management, aiming to turn operational know-how into higher-margin data assets, but the stock remains volatile near record lows after a recent reverse split and has not confirmed robot-driven revenue or margin gains.
Tencent Shares Gain After $4.66B Bond Sale Seen Fueling AI Bets

Tencent Shares Gain After $4.66B Bond Sale Seen Fueling AI Bets

10 June 2026
Tencent shares jumped 3.22% to HK$467.80 after the company priced a larger-than-expected US$4.66 billion dual-currency bond deal, drawing over US$17 billion in orders and allowing tighter pricing, as investors weighed Tencent’s ability to fund rising AI investments while maintaining strong cash flow and ongoing share buybacks.
PAVS Stock Jumps Again, $195M Share Sale Filing in Focus

PAVS Stock Jumps Again, $195M Share Sale Filing in Focus

10 June 2026
Paranovus Entertainment Technology shares jumped 19.6% premarket after filing plans for an at-the-market share sale of up to $194.99 million—an unusually large amount compared to its $1.07 million market value—raising dilution risks as the company can sell shares at prevailing prices with no minimums, while recent trading has been highly volatile and underlying operations remain limited.
Go toTop